Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: ARMIS BIOPHARMA, INC.
Awarding agency: Department of Defense / Defense Threat Reduction Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2023-08-09 to 2025-02-08
Current total value of award: $5759320.63
Description: RESEARCH AND DEVELOPMENT TO SUPPORT VERIOX DECONTAMINATION KIT TO TREAT CHEMICAL WEAPON AGENTS